Journal
ARCHIVES OF GENERAL PSYCHIATRY
Volume 66, Issue 8, Pages 848-856Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/archgenpsychiatry.2009.81
Keywords
-
Categories
Funding
- National Institutes of Health (NIH)
- Agency for Healthcare Research and Quality
- American Foundation for Suicide Prevention
- National Association for Research on Schizophrenia and Affective Disorders
- New York State Office of Mental Health
- AstraZeneca, PLC
- Bristol-Myers Squibb Co
- Eli Lilly and Company
- Ortho-McNeil Janssen Scientific Affairs, LLC
- NIH
- National Patent Safety Foundation
- Bristol-Myers Squibb Co
- AstraZeneca, PLC
- Agency for Healthcare Research and Quality [U18-HS016097]
- National Alliance for Research on Schizophrenia and Depression
Ask authors/readers for more resources
Context: Antidepressants have recently become the most commonly prescribed class of medications in the United States. Objective: To compare sociodemographic and clinical patterns of antidepressant medication treatment in the United States between 1996 and 2005. Design: Analysis of antidepressant use data from the 1996 (n=18 993) and 2005 (n=28 445) Medical Expenditure Panel Surveys. Setting: Households in the United States. Participants: Respondents aged 6 years or older who reported receiving at least 1 antidepressant prescription during that calendar year. Main Outcome Measures: Rate of antidepressant use and adjusted rate ratios (ARRs) of year effect on rate of antidepressant use adjusted for age, sex, race/ethnicity, annual family income, self-perceived mental health, and insurance status. Results: The rate of antidepressant treatment increased from 5.84% (95% confidence interval [CI], 5.47-6.23) in 1996 to 10.12% (9.58-10.69) in 2005 (ARR, 1.68; 95% CI, 1.55-1.81), or from 13.3 to 27.0 million persons. Significant increases in antidepressant use were evident across all sociodemographic groups examined, except African Americans (ARR, 1.13; 95% CI, 0.89-1.44), who had comparatively low rates of use in both years (1996, 3.61%; 2005, 4.51%). Although antidepressant treatment increased for Hispanics (ARR, 1.75; 95% CI, 1.60-1.90), it remained comparatively low (1996, 3.72%; 2005, 5.21%). Among antidepressant users, the percentage of patients treated for depression did not significantly change (1996, 26.25% vs 2005, 26.85%; ARR, 0.95; 95% CI, 0.83-1.07), although the percentage of patients receiving antipsychotic medications (5.46% vs 8.86%; ARR, 1.77; 95% CI, 1.31-2.38) increased and those undergoing psychotherapy declined (31.50% vs 19.87%; ARR, 0.65; 95% CI, 0.56-0.72). Conclusions: From 1996 to 2005, there was a marked and broad expansion in antidepressant treatment in the United States, with persisting low rates of treatment among racial/ethnic minorities. During this period, individuals treated with antidepressants became more likely to also receive treatment with antipsychotic medications and less likely to undergo psychotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available